Three-Dimensional-QSAR and Relative Binding Affinity Estimation of Focal Adhesion Kinase Inhibitors

Suparna Ghosh1, Seung Joo Cho1,2

  • 1Department of Biomedical Sciences, College of Medicine, Chosun University, Gwangju 501-759, Republic of Korea.

Insights

Computational modeling accurately predicts FAK inhibitors for cancer therapy. Combining machine learning (ML) and physics-based methods enhances drug discovery for focal adhesion kinase (FAK) targeting.

Area of Science:

  • Computational chemistry
  • Drug discovery
  • Molecular modeling

Background:

  • Precise binding affinity predictions are crucial for structure-based drug discovery (SBDD).
  • Focal adhesion kinase (FAK) is a key target in oncology due to its overexpression in various cancers.
  • FAK inhibition represents a promising therapeutic strategy for cancer treatment.

Purpose of the Study:

  • To computationally model and predict the binding affinity of small molecule inhibitors targeting FAK.
  • To explore the synergy between machine learning (ML) and physics-based approaches for optimizing FAK inhibitors.

Main Methods:

  • Employed three-dimensional quantitative structure-activity relationship (3D-QSAR) methods (CoMFA, CoMSIA) utilizing supervised ML.
  • Utilized molecular dynamics (MD) simulations and MM-PB/GBSA for analyzing binding interactions.
  • Applied alchemical free energy perturbation (FEP) simulations to estimate relative binding free energies.

Main Results:

  • 3D-QSAR studies demonstrated reasonable statistical accuracy in correlating physicochemical properties with inhibitory activities.
  • MD simulations provided insights into residue-specific binding interactions within the FAK active site.
  • Computed relative binding free energies showed acceptable agreement with experimental data.

Conclusions:

  • Hybrid approaches combining ML (3D-QSAR) and physics-based simulations (MD, FEP) are effective for rational drug design.
  • These integrated computational strategies can accelerate the optimization of lead compounds targeting FAK.
  • The study highlights the potential of synergistic computational methods in structure-based drug discovery for oncology.

Related Concept Videos

The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
13.1K
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.1K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
833
Protein-Drug Binding: Determination Methods01:22

Protein-Drug Binding: Determination Methods

Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
255
Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
13.0K